Aizen Therapeutics

Aizen Therapeutics is an artificial intelligence company in San Diego, United States, founded in 2022. It has raised $13.0M across 1 round, most recently a $13.0M Seed in November 2024.

Employees
1–10
Founded
2022
Business Model
B2B
Total Funding
$13.0M
Last Round
$13.0M SeedNov 2024
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.

About

Aizen is an AI-native biotechnology company pioneering oral peptides to transform the lives of patients and families burdened by chronic immune disorders. Powered by DaX, a foundational AI platform developed by Caltech faculty, the company designs de novo peptides that transcend natural biology through the chemical landscape of non-canonical amino acids. Headquartered in San Diego, Aizen is advancing a proprietary pipeline of gut-restricted and systemic oral biologics while collaborating with global biopharma partners.

Summary

It lists 1–10 employees. It has raised $13.0M in total across 1 round, most recently a $13.0M Seed round in Nov 2024. Investors include Madrona Venture and Cercano Management.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
SeedSeed RoundNov 2024
$13.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series G+Total funding$3.5BOct 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Aizen Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/aizen-therapeutics"><img src="https://indexed.vc/api/badge/company/aizen-therapeutics" alt="Aizen Therapeutics on Indexed.vc" width="260" height="76" /></a>